This did not reach statistical significance possibly due to the high inter and intra assay variability reported in p24 antigen production in ex vivo biopsy challenge experiments, especially at baseline and the small sample size [ 68 ].
← all excerpts
Randomized, placebo controlled phase I trial of the safety, pharmacokinetics, pharmacodynamics and acceptability of a 90 day tenofovir plus levonorgestrel vaginal ring used continuously or cyclically in women: The CONRAD 138 study.
1
—
—